Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-19

Clinical Trial Update: The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of Lansoprazole for patients with Coronary Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)

Snippet

Sponsor: Daejeon St. Mary's hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN